Before group | After group | pvalue | |
---|---|---|---|
(n = 20) | (n = 23) | ||
Age, median [IQR], years | 63.5 [59;67] | 69 [65; 84] | 0.09 |
Female sex (%) | 10 (50) | 13 (56) | 0.76 |
Nadir platelet count, median [IQR]/mm3 | 84,000 [52,000; 98,000] | 34,000 [17,000; 76,000] | 0.09 |
Hemofiltration (%) | 8 (40) | 14 (61) | 0.22 |
Cirrhosis (%) | 2 (10) | 4 (17) | 0.67 |
Sepsis (%) | 20 (100) | 17 (74) | 0.23 |
Death in ICU (%) | 6 (30) | 15 (65) | 0.03 |
SAPS II, median [IQR] | 52.5 [41; 63] | 72.5 [55; 78] | 0.2 |
SOFA score, median [IQR] | 11.5 [7; 15] | 17 [9; 18] | 0.1 |
Thrombocytopenia at admission to ICU (%) | 10 (50%) | 16 (70%) | 0.23 |
Time from ICU admission to occurrence of thrombocytopenia, median [IQR], days | 1.5 [1; 2] | 1 [1; 2] | NS |
Platelet transfusion, n (%) | 2 (10%) | 1 (4.3%) | 0.59 |
Medical admissions | 10 (50%) | 18 (78%) | 0.06 |